Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
WCAS XIV has agreed to acquire Select Medical Holdings, a healthcare services other business in Pennsylvania, for $16.50. Select Medical Holdings operates healthcare services including inpatient and outpatient care delivery, supporting patient treatment across its network in PA. WCAS XIV acquisitions in healthcare M&A focus on scaling healthcare services other platforms and strengthening operational performance in Pennsylvania. The going private acquisition is structured through a merger where MergerSub combines with Select Medical Holdings, with WCAS XIV as the private equity buyer. The announced deal is tied to a Merger Agreement dated March 2, 2026, with stockholder approval and an advisory vote on executive compensation.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026